N/A N=12 Erectile Rating During the Treatment of Rectal Cancers Localized
Rectal Cancer Stage I
Primary: Proportion of Patients With Erectile Dysfunction Induced by Medical and Surgical Treatment of Rectal Cancer — 0 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=76 A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Ejaculatory Dysfunction · Hypogonadism
Primary: Change From Baseline in the Male Sexual Health Questionnaire-Ejaculatory Dysfunction-Short Form (MSHQ-EjD-SF) Ejaculatory Function Score at 16 Weeks — 3.61; 2.95 units…
N/A N=35 SSRI Effects on Semen Parameters in Men
Healthy
Primary: Semen Volume — 2.55 mL
N/A N=98,832 Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor
Erectile Dysfunction · Cardiovascular Diseases · Male Urogenital Diseases
Primary: Percentage of Participants With Underlying Condition Until Day -1 of the Index PDE5i Prescription — 70.23; 55.73 Percentage of participants — p=<0.001
N/A N=20 MED3000 Topical Gel for On-Demand Treatment of Post-Radical Prostatectomy Erectile Dysfunction
Erectile Dysfunction Following Radical Prostatectomy
Primary: Whether the Erectile Function Domain of the International Index of Erectile Function Mean Change From Baseline Met or Exceeded the Minimally Clinically Important…
Phase 4 N=140 Effect of Testosterone in Men With Erectile Dysfunction
Erectile Dysfunction · Testosterone Deficiency · Diabetes
Primary: Change From Baseline in Erectile Function Domain Score of the International Index of Erectile Function (IIEF) — 19.6; 20.1; 21.3; 21.3 units on a scale
N/A N=20 Penile Nerve Stimulation for Treatment of Delayed Ejaculation
Delayed Ejaculation
Primary: International Index of Erectile Function (IIEF) Scale Score — 7.5; 9.7 score on a scale
Phase 3 N=192 Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction
Erectile Dysfunction
Primary: Change From Baseline in the Erectile Function (EF) Domain of the International Index of Erectile Function (IIEF) Questionnaire, in Patients Randomised to MED3000, at…
Phase 3 N=117 Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia
Alopecia
Primary: Number of Participants With Adverse Events (AE) Related to Sexual Function in the Double-blind Treatment Period — 5; 9 Participants — p=0.27
Phase 4 N=176 Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied
Impotence
Primary: Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8) — 80.27; 62.15 scores on a scale — p=<0.0001
Phase 2 N=20 Mirabegron For Erectile Dysfunction
Erectile Dysfunction · Overactive Bladder · Urinary Incontinence
Primary: Erectile Function Assessed by IIEF Questionnaire — 12.7 score on a scale
Phase 3 N=74 An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms
Erectile Dysfunction · Lower Urinary Tract Symptoms
Primary: Change From Baseline Erectile Function Domain of the International Index of Erectile Function — 2.84; 2.84 Change in EF Domain Score from Baseline
Phase 4 N=623 A Study in Erectile Dysfunction
Erectile Dysfunction
Primary: Percentage of Participants Having an International Index of Erectile Function - Erectile Function (IIEF-EF) Domain Score Greater Than or Equal to 26 Through 12-Week…
Phase 2 N=80 Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men
Sexual Dysfunctions, Psychological · Hypoactive Sexual Desire Disorder · Erectile Dysfunctions
Primary: Number of Participants With a Score of ≤2 (Much/Very Much Improved) on the Clinical Global Impression Scale Adapted for Sexual Function (CGI-SF) at Week 6 Between…
N/A N=80 Radial Shockwave Therapy for Erectile Dysfunction
Erectile Dysfunction
Primary: Change IIEF-EF Score — 3.4; 4.2 units on a scale
Phase 3 N=618 Treatment of Erectile Dysfunction I
Erectile Dysfunction
Primary: Change in Erectile Function Domain Assessed by International Index of Erectile Function (IIEF), Baseline to Final Visit/Week 12, mITT (Modified Intent-to-Treat), LOCF…
Phase 3 N=601 Treatment of Erectile Dysfunction II
Erectile Dysfunction
Primary: Change in Erectile Function Domain Assessed by International Index of Erectile Function (IIEF), Baseline to Final Visit/Week 12, mITT (Modified Intent-to-Treat), LOCF…
Phase 4 N=383 A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China
Erectile Dysfunction
Primary: Percentage of Participants Preferring Tadalafil Over Sildenafil Measured at Week 18 Using Question 1 of the "Phosphodiesterase 5 Inhibitor Treatment Preference"…
Phase 4 N=40 Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder
Hypoactive Sexual Desire Disorder
Primary: Changes in Blood Oxygen Level Dependent (BOLD) Signal Change on Functional MRI — 9.98; 7.67 BOLD signal change
Phase 2 N=232 Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
Erectile Dysfunction
Primary: Erectile Function (EF) Domain Score of the International Index of Erectile Function (IIEF) — 18.5; 19.6 score on a scale — p=0.0132
N/A N=80 A Trial to Evaluate the Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Sexual Function in Men With Erectile Dysfunction
Healthy Subjects(Only Men)
Primary: Changes in EF(Erectile Function) Domain — 11.53; 12.89; 14.56; 16.46 Scores on a scale
Phase 3 N=342 Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
Impotence
Primary: Change From Baseline to Endpoint in the International Index of Erectile Function (IIEF)- Erectile Function Domain Score (Sum of IIEF Questions 1-5 and 15) — 0.49; 8.03…
Phase 3 N=16 Safety and Effectiveness Study of Maca Root to Treat Antidepressant-Induced Sexual Dysfunction
Depression · Sexual Dysfunction
Primary: Change in Massachusetts General Hospital Sexual Dysfunction Inventory Scores — .249; .017 score on a scale — p=.016
Phase 4 N=150 Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
Erectile Dysfunction · Metabolic Syndrome
Primary: Change From Baseline in International Index of Erectile Function - Erectile Function Domain (IIEF-EF) Subscore at Week 8 or Last Observation Carried Forward (LOCF)…
N/A N=178 Sexual Function and Wellbeing in Males With Rectal Cancer
Rectal Cancer
Primary: Change in Serum Testosterone Levels Between Baseline and After Preoperative Radiotherapy. — 11.3; 11.9; 9.3 nmol/L — p=0.014
Phase 2 N=894 A Study of LY900010 in Erectile Dysfunction
Erectile Dysfunction
Primary: Change From Baseline to 12 Week Endpoint in International Index of Erectile Function (IIEF) Erectile Function (EF) Domain Score — 2.515; 2.405; -0.971; 3.530 units on a…
N/A N=110 Penile Length Restoration in Men With Diabetes Mellitus, Type II
Diabetes Mellitus, Type 2 · Penile Diseases
Primary: Penile Length Change Between Baseline and Month 6 — 0; 0.5; 0.5; 0.8 Median change from baseline (cm)
Phase 2 N=12 H-22411: BOTOX® for Peyronie's Disease
Peyronie's Disease
Primary: Average Percent Change of Penile Curvature in Degrees — -21.73; 2.429 percent change — p=0.5154
Phase 4 N=100 AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment
Depressive Disorder, Major
Primary: 21-item Hamilton Depression Rating Scale Score (HAM-D) — 13.5; 15.6 units on a scale — p=0.71
N/A N=1,459 Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
Priapism · Anemia, Sickle Cell
Primary: Enumeration of the Prevalence of Priapism in Males With Sickle Cell Anemia and Sickle Beta Zero Thalassemia. — 18; 58; 160; 189 participants